{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:25:15Z","timestamp":1771064715398,"version":"3.50.1"},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[1999,12]]},"abstract":"<jats:p> PURPOSE: Isolated meningeal relapse in children with acute lymphoblastic leukemia (ALL) usually has been followed by bone marrow relapse and limited survival. The purpose of this study was to prevent marrow relapse by administering intensive therapy before delayed craniospinal radiation. <\/jats:p><jats:p> PATIENTS AND METHODS: Eighty-three patients with ALL in first bone marrow remission with an isolated CNS relapse were treated with systemic chemotherapy known to enter into the CSF and intrathecal chemotherapy for 6 months. Craniospinal irradiation (24 Gy cranial\/15 Gy spinal) was then administered, followed by 1.5 years of maintenance chemotherapy. <\/jats:p><jats:p> RESULTS: All 83 patients achieved a second remission. The 4-year event-free survival (EFS) rate was 71.1% \u00b1 5.3%. There was a fourfold increased risk of relapse for children whose initial remission was less than 18 months. The 4-year EFS rate for patients with a first complete remission \u2265 18 months was 83.3% \u00b1 5.3%, and for those with a first complete remission less than 18 months, it was 46.2% \u00b1 10.2% (P = .0002.) There was a low incidence of neurologic toxicity and an unexpectedly high rate of allergic reactions to l-asparaginase. Five patients developed secondary malignancies: two with acute nonlymphoblastic leukemia during therapy, one with myelodysplasia after therapy, and two with brain tumors 1.5 to 2 years after cessation of therapy. <\/jats:p><jats:p> CONCLUSION: For children with ALL and an isolated CNS relapse, treatment that delays definitive craniospinal irradiation by 6 months to allow for more intensive systemic and intrathecal chemotherapy results in better EFS than has been previously reported. Using this approach, the long-term prognosis for children with first complete remission \u2265 18 months is comparable to that at the time of original diagnosis of ALL. <\/jats:p>","DOI":"10.1200\/jco.1999.17.12.3745","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:32:09Z","timestamp":1487917929000},"page":"3745-3752","source":"Crossref","is-referenced-by-count":111,"title":["Improved Survival of Children With Isolated CNS Relapse of Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study"],"prefix":"10.1200","volume":"17","author":[{"given":"A. Kim","family":"Ritchey","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, West Virginia University Health Sciences Center, Morgantown, WV; Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida, Gainesville, FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Radiation Therapy, Walter Reed Medical Center, Washington, DC; and Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad H.","family":"Pollock","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, West Virginia University Health Sciences Center, Morgantown, WV; Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida, Gainesville, FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Radiation Therapy, Walter Reed Medical Center, Washington, DC; and Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Lauer","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, West Virginia University Health Sciences Center, Morgantown, WV; Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida, Gainesville, FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Radiation Therapy, Walter Reed Medical Center, Washington, DC; and Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Andejeski","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, West Virginia University Health Sciences Center, Morgantown, WV; Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida, Gainesville, FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Radiation Therapy, Walter Reed Medical Center, Washington, DC; and Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Buchanan","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, West Virginia University Health Sciences Center, Morgantown, WV; Pediatric Oncology Group Statistical Office and Department of Statistics, University of Florida, Gainesville, FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Radiation Therapy, Walter Reed Medical Center, Washington, DC; and Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-3745","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6014.864"},{"key":"R2-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.6.776"},{"key":"R3-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.10.1646"},{"key":"R4-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.5.839"},{"key":"R5-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2840"},{"key":"R6-3745","unstructured":"Mahoney  DH,  Nitschke  R,  Shuster  J, et al: Comparison of intensive methotrexate\/mercaptopurine (MTX\/MP) vs.  low-dose repetitive (LD) MTX\/MP for lower risk ALL (LR-ALL): A Pediatric Oncology Group randomized phase III study. Proc Am Soc Clin Oncol 15:366,1996,  (abstr)"},{"key":"R7-3745","unstructured":"Lauer  SJ,  Tolenado  S,  Winick  N, et al: A comparison of early intensive methotrexate\/mercaptopurine (MTX\/MP) vs early intensive alternating chemotherapy for high-risk acute lymphoblastic leukemia (HR-ALL): A Pediatric Oncology Group randomized phase III study.  Proc Am Soc Clin Oncol 14:342,1995,  (abstr)"},{"key":"R8-3745","unstructured":"Ritchey  AK,  Newman  EM: Clinical impact and pharmacokinetics of intravenous (IV) 6 -mercaptopurine (MP) in children with isolated central nervous system (CNS) leukemia: A Pediatric Oncology Group study.  Proc Am Soc Clin Oncol 13:318,1994,  (abstr)"},{"key":"R10-3745","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R11-3745","doi-asserted-by":"crossref","unstructured":"Cox  DR: Regression models and life tables.  J Royal Stat Soc 34:187,1972-220,","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"R12-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.1.18"},{"key":"R13-3745","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3122.3122"},{"key":"R14-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.911"},{"key":"R15-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2840"},{"key":"R16-3745","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382304"},{"key":"R17-3745","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80196-X"},{"key":"R18-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.359"},{"key":"R19-3745","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb08544.x"},{"key":"R20-3745","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890515)63:10<2066::AID-CNCR2820631032>3.0.CO;2-I"},{"key":"R21-3745","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850701)56:1<81::AID-CNCR2820560114>3.0.CO;2-2"},{"key":"R22-3745","doi-asserted-by":"crossref","unstructured":"Winick  NJ,  Smith  SD,  Shuster  J, et al: Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.  J Clin Oncol 11:272,1993-278,","DOI":"10.1200\/JCO.1993.11.2.271"},{"key":"R23-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.333"},{"key":"R24-3745","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00344-K"},{"key":"R25-3745","doi-asserted-by":"publisher","DOI":"10.1016\/S0308-2261(78)80008-3"},{"key":"R26-3745","unstructured":"Green  DM,  Baski  S,  West  CR, et al: The use of subcutaneous cerebrospinal fluid reservoirs for the prevention and treatment of meningeal relapse of acute lymphoblastic leukemia.  Am J Pediatr Hematol\/Oncol 4:147,1982-154,"},{"key":"R27-3745","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900801)66:3<447::AID-CNCR2820660308>3.0.CO;2-5"},{"key":"R28-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.2.202"},{"key":"R29-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.7.998"},{"key":"R30-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.365"},{"key":"R31-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.2.98"},{"key":"R32-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.10.1539"},{"key":"R33-3745","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.399"},{"key":"R34-3745","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930701)72:1<261::AID-CNCR2820720146>3.0.CO;2-O"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.1999.17.12.3745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:28:43Z","timestamp":1653514123000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.1999.17.12.3745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1200\/JCO.1999.17.12.3745"],"URL":"https:\/\/doi.org\/10.1200\/jco.1999.17.12.3745","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}